Cost of Drugs, Marketing and Managed Markets Grabbing Pharma Headlines

, ,
The rising costs of medical care is a concern across the board. This week, the discussion centered on cancer drug pricing at the annual American Society of Clinical Oncology (ASCO) meeting. While the ASCO drives discussion about cancer drug’s…

6 Articles Showcasing Pharma M&A on the Rise

The acquisition of Par Pharma by rival Endo for $8 billion has many in the Pharma industry forecasting a continued M&A frenzy. The heightened activity for mergers and acquisitions also brings with it a challenge. More often than not, mergers…

Finally, A Solution to Managed Markets Data Overload

Are your Account Managers drowning in data?  Can your Sales Reps easily develop a target list of prescribers where you know you have preferred formulary access? Is your organization taking advantage of Managed Market data to capitalize its…